A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor

NCT01128842 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumors

Interventions

DRUG: Neratinib
DRUG: Capecitabine

Sponsor

Puma Biotechnology, Inc.